Craft

Cassava Sciences

Stock Price

$26.5

2024-10-29

Market Capitalization

$1.3 B

2024-10-29

Cassava Sciences Summary

Company Summary

Overview
Cassava Sciences (formerly known as Pain Therapeutics) is a clinical-stage biotechnology company that specializes in drug development. It offers preclinical development, clinical development, medical affairs, regulatory, pharmaceutical development, and supply chain management solutions. The company focuses on the detection and treatment of neurodegenerative diseases, such as Alzheimer’s.
Type
Public
Status
Active
Founded
1998
HQ
Austin, TX, US | view all locations
Website
https://www.cassavasciences.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Remi Barbier

    Remi Barbier, Chairman of the Board, President & CEO

    • Nadav Friedmann

      Nadav Friedmann, Chief Medical Officer and Director

    • Richard J. Barry

      Richard J. Barry, Independent Director

      • Eric Schoen

        Eric Schoen, Chief Financial Officer

      LocationsView all

      1 location detected

      • Austin, TX HQ

        United States

        6801 N Capital of Texas Hwy Building 1, Suite 300

      Cassava Sciences Financials

      Summary Financials

      Net income (Q3, 2024)
      ($27.9M)
      Cash (Q3, 2024)
      $149.0M
      EBIT (Q3, 2024)
      ($30.6M)

      Footer menu